Saturday December 12, 1998 - Question 8

Which of the following statements about the clinical manifestations of beta-adrenergic receptor antagonist toxicity is correct?

A. Bronchospasm is a common finding in beta-adrenergic receptor antagonist toxicity.
 
B. Patients with asthma are known to be at an increased risk for bronchospasm due to beta adrenergic receptor antagonist toxicity.
 
C. There is no risk of bronchospasm with beta-1 selective agents.
 
D. Hypoglycemia rarely occurs in beta adrenergic receptor antagonist toxicity.
 
E. Onset of toxicity is usually delayed for 12 to 24 hours due to slow distribution to tissue sites.
 
 

Discussion